Penserra Capital Management LLC Provention Bio, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.59 - $7.39 $8,105 - $10,715	-1,450 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $28 - $41	5 Added 0.35%	1,450 $9,000
Q2 2021 Aug 12, 2021	BUY	$6.71 - $11.04 $67 - $110	10 Added 0.7%	1,445 $12,000
Q1 2021 May 13, 2021	BUY	$10.12 - $19.45 $1,163 - $2,236	115 Added 8.71%	1,435 $15,000
Q4 2020 Feb 12, 2021	BUY	$11.79 - $18.94 $15,562 - $25,000	1,320 New	1,320 $22,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.